Joel G. Turner

4.3k total citations · 1 hit paper
75 papers, 3.3k citations indexed

About

Joel G. Turner is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Joel G. Turner has authored 75 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 23 papers in Oncology and 15 papers in Hematology. Recurrent topics in Joel G. Turner's work include Nuclear Structure and Function (14 papers), Multiple Myeloma Research and Treatments (12 papers) and Immunotherapy and Immune Responses (12 papers). Joel G. Turner is often cited by papers focused on Nuclear Structure and Function (14 papers), Multiple Myeloma Research and Treatments (12 papers) and Immunotherapy and Immune Responses (12 papers). Joel G. Turner collaborates with scholars based in United States, United Kingdom and Canada. Joel G. Turner's co-authors include Daniel M. Sullivan, Ned H. Kalin, Jana L. Dawson, Lorey K. Takahashi, Ian Jacobs, D Oram, Chris Frost, J. G. Grudzinskas, Hua Yu and Douglas C. Marchion and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Joel G. Turner

72 papers receiving 3.2k citations

Hit Papers

A risk of malignancy index incorporating CA 125, ultrasou... 1990 2026 2002 2014 1990 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer
    1990 693 citations Joel G. Turner et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joel G. Turner United States 27 1.5k 818 638 463 432 75 3.3k
Daniela M. Dinulescu United States 24 1.9k 1.3× 1.1k 1.3× 856 1.3× 432 0.9× 255 0.6× 50 4.3k
Jennie P. Mather United States 46 3.8k 2.6× 607 0.7× 2.3k 3.6× 409 0.9× 93 0.2× 124 7.2k
Clifford Librach Canada 35 1.0k 0.7× 201 0.2× 2.0k 3.1× 893 1.9× 944 2.2× 166 4.7k
Hiroshi Tsuda Japan 34 1.2k 0.8× 471 0.6× 590 0.9× 1.3k 2.8× 732 1.7× 150 4.1k
Douglas A. Kniss United States 35 966 0.7× 233 0.3× 161 0.3× 614 1.3× 430 1.0× 98 3.1k
Kenji Takakura Japan 35 926 0.6× 1.2k 1.5× 1.6k 2.5× 1.9k 4.0× 809 1.9× 92 4.6k
Linda A. Schuler United States 35 1.4k 0.9× 1.3k 1.6× 220 0.3× 407 0.9× 148 0.3× 102 4.2k
Gottfried Dohr Austria 37 768 0.5× 234 0.3× 416 0.7× 1.5k 3.2× 1.1k 2.7× 120 3.5k
Enrico Crivellato Italy 43 2.3k 1.6× 870 1.1× 109 0.2× 1.9k 4.1× 110 0.3× 172 5.5k
K. Miyazaki Japan 34 1.3k 0.9× 502 0.6× 1.4k 2.1× 627 1.4× 1.1k 2.6× 94 4.2k

Countries citing papers authored by Joel G. Turner

Since Specialization
Citations

This map shows the geographic impact of Joel G. Turner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel G. Turner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel G. Turner more than expected).

Fields of papers citing papers by Joel G. Turner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel G. Turner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel G. Turner. The network helps show where Joel G. Turner may publish in the future.

Co-authorship network of co-authors of Joel G. Turner

This figure shows the co-authorship network connecting the top 25 collaborators of Joel G. Turner. A scholar is included among the top collaborators of Joel G. Turner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel G. Turner. Joel G. Turner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhai, Dong, et al.. (2025). Bioactive glass fiber mat delivering Zn ions for full-thickness wound regeneration. Ceramics International. 51(18). 26085–26097. 1 indexed citations
2.
Tallia, Francesca, Steven Chen, Joel G. Turner, et al.. (2024). Calcium sources can increase mechanical properties of 3D printed bioactive hybrid bone scaffolds. RSC Advances. 14(51). 37846–37858.
3.
Turner, Joel G., et al.. (2023). The effect of Si species released from bioactive glasses on cell behaviour: A quantitative review. Acta Biomaterialia. 170. 39–52. 18 indexed citations
4.
Turner, Joel G., Yan Cui, Jana L. Dawson, et al.. (2020). Melphalan and Exportin 1 Inhibitors Exert Synergistic Antitumor Effects in Preclinical Models of Human Multiple Myeloma. Cancer Research. 80(23). 5344–5354. 15 indexed citations
5.
Sweet, Kendra, Rami S. Komrokji, Eric Padron, et al.. (2019). Phase I Clinical Trial of Selinexor in Combination with Daunorubicin and Cytarabine in Previously Untreated Poor-Risk Acute Myeloid Leukemia. Clinical Cancer Research. 26(1). 54–60. 22 indexed citations
6.
7.
Baz, Rachid, Jeffrey A. Zonder, Kenneth H. Shain, et al.. (2017). Phase I/II Study of Liposomal Doxorubicin (DOX) in Combination with Selinexor (SEL) and Dexamethasone (Dex) for Relapsed and Refractory Multiple Myeloma (RRMM). Blood. 130. 3095–3095. 7 indexed citations
8.
Turner, Joel G., Jana L. Dawson, Steven Grant, et al.. (2014). 220 Overcoming drug-resistance in multiple myeloma by XPO1 inhibitor combination therapy. European Journal of Cancer. 50. 74–75. 1 indexed citations
9.
Turner, Joel G., Jana L. Dawson, & Daniel M. Sullivan. (2011). Nuclear export of proteins and drug resistance in cancer. Biochemical Pharmacology. 83(8). 1021–1032. 268 indexed citations
10.
11.
Gump, Jana, Douglas C. Marchion, Elona Biçaku, et al.. (2006). Valproic acid sensitizes human melanoma cells to karenitecin in vitro and in vivo. Cancer Research. 66. 320–320.
12.
Turner, Joel G., Jana Gump, Bernadette Ferraro, & Daniel M. Sullivan. (2005). Nuclear and cytoplasmic topoisomerase II alpha are differentially phosphorylated and nuclear export is blocked by CRM1 antisense oligonucleotides. Cancer Research. 65. 1399–1399. 1 indexed citations
13.
Turner, Joel G., Alexander L. Rakhmilevich, Lyudmila G. Burdelya, et al.. (2001). Anti-CD40 Antibody Induces Antitumor and Antimetastatic Effects: The Role of NK Cells. The Journal of Immunology. 166(1). 89–94. 90 indexed citations
14.
Niu, Guilian, Jun Tan, Joel G. Turner, et al.. (2000). Bing De Ling, a Chinese Herbal Formula, Stimulates Multifaceted Immunologic Responses in Mice. DNA and Cell Biology. 19(8). 515–520. 5 indexed citations
15.
Shtil, Аlexander А., Joel G. Turner, William S. Dalton, & Hua Yu. (2000). Alternative Pathways of Cell Death to Circumvent Pleiotropic Resistance in Myeloma Cells: Role of Cytotoxic T-Lymphocytes. Leukemia & lymphoma. 38(1-2). 59–70. 3 indexed citations
16.
Takahashi, Lorey K., Joel G. Turner, & Ned H. Kalin. (1998). PROLONGED STRESS-INDUCED ELEVATION IN PLASMA CORTICOSTERONE DURING PREGNANCY IN THE RAT: IMPLICATIONS FOR PRENATAL STRESS STUDIES. Psychoneuroendocrinology. 23(6). 571–581. 152 indexed citations
17.
Mao, Weiguang, Rosalyn Irby, Domenico Coppola, et al.. (1997). Activation of c-Src by receptor tyrosine kinases in human colon cancer cells with high metastatic potential. Oncogene. 15(25). 3083–3090. 171 indexed citations
18.
Mahvi, David M., Joseph K. Burkholder, Joel G. Turner, et al.. (1996). Particle-Mediated Gene Transfer of Granulocyte-Macrophage Colony-Stimulating Factor cDNA to Tumor Cells: Implications for a Clinically Relevant Tumor Vaccine. Human Gene Therapy. 7(13). 1535–1543. 71 indexed citations
19.
Takahashi, Lorey K., Joel G. Turner, & Ned H. Kalin. (1992). Prenatal stress alters brain catecholaminergic activity and potentiates stress-induced behavior in adult rats. Brain Research. 574(1-2). 131–137. 206 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniela M. Dinulescu Breakdown of academic impact, for papers by Jennie P. Mather Breakdown of academic impact, for papers by Clifford Librach Breakdown of academic impact, for papers by Hiroshi Tsuda Breakdown of academic impact, for papers by Douglas A. Kniss Breakdown of academic impact, for papers by Kenji Takakura Breakdown of academic impact, for papers by Linda A. Schuler Breakdown of academic impact, for papers by Gottfried Dohr Breakdown of academic impact, for papers by Enrico Crivellato Breakdown of academic impact, for papers by K. Miyazaki
Rankless by CCL
2026